Tentative US FDA approval for Orchid's generic gemifloxacin
This article was originally published in Scrip
Executive Summary
Orchid Chemicals and Pharmaceuticals has received tentative US FDA approval for its ANDA for gemifloxacin mesylate tablets 320mg, a generic version of Cornerstone Therapeutics' fluoroquinolone antibacterial, Factive.